Stefan T Engelter Selected Research

Biomarkers (Surrogate Marker)

1/2021	Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.
9/2020	Biomarkers and antithrombotic treatment in cervical artery dissection - Design of the TREAT-CAD randomised trial.
1/2019	A novel biomarker-based prognostic score in acute ischemic stroke: The CoRisk score.
1/2019	Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.
1/2003	Infarct volume on apparent diffusion coefficient maps correlates with length of stay and outcome after middle cerebral artery stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan T Engelter Research Topics

Disease

60	Stroke (Strokes) 06/2022 - 11/2006
40	Ischemic Stroke 06/2022 - 09/2010
14	Atrial Fibrillation 01/2022 - 01/2016
10	Carotid Stenosis (Carotid Artery Stenosis) 11/2019 - 10/2008
9	Hemorrhage 01/2022 - 03/2014
8	Cerebral Hemorrhage 01/2022 - 03/2013
7	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 07/2011
5	Blood Vessel Dissection 01/2021 - 09/2007
5	Infarction (Infarctions) 09/2020 - 01/2003
4	Brain Ischemia (Cerebral Ischemia) 09/2021 - 02/2013
2	Transient Ischemic Attack 01/2022 - 01/2022
2	Ischemia 09/2020 - 01/2011
2	Hematoma 11/2018 - 05/2017
2	Pathologic Constriction (Stenosis) 01/2017 - 01/2012
1	Leukocytosis (Pleocytosis) 10/2022
1	Hypertension (High Blood Pressure) 05/2022
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 05/2022
1	COVID-19 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Brain Infarction 01/2022
1	Embolic Stroke 01/2022
1	Epilepsy (Aura) 08/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Hypercholesterolemia 01/2020
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 05/2014
1	Leukoencephalopathies 02/2014
1	Atherosclerosis 01/2012
1	Cerebral Infarction 01/2011
1	Mannose-Binding Protein Deficiency 01/2011
1	Delirium 01/2010
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2003

Drug/Important Bio-Agent (IBA)

27	AnticoagulantsIBA 01/2022 - 09/2007
15	Vitamin K FDA Link 01/2022 - 09/2015
7	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2021 - 11/2006
5	RivaroxabanIBA 01/2022 - 01/2017
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2003
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 02/2013
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 09/2020
4	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 12/2009
3	C-Reactive ProteinIBA 10/2022 - 12/2009
3	N(4)-oleylcytosine arabinosideIBA 11/2018 - 09/2015
2	Tenecteplase FDA Link 05/2022 - 10/2021
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 09/2020
2	edoxabanIBA 02/2021 - 01/2019
2	apixabanIBA 02/2021 - 01/2019
2	Dabigatran FDA Link 02/2021 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 01/2018 - 03/2014
2	2,6-dinitrotoluene (DNT)IBA 01/2017 - 10/2013
2	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 03/2014 - 07/2011
1	CreatinineIBA 01/2022
1	poly(dG-dA)n.poly(dC-dT)n (((GA)n))IBA 01/2022
1	Cystatin CIBA 01/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Phenprocoumon (Liquamar)FDA Link 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	AcenocoumarolIBA 01/2021
1	Retinaldehyde (Retinal)IBA 09/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	Heparinoids (Heparinoid)IBA 01/2019
1	ThrombomodulinIBA 01/2018
1	activated protein C receptorIBA 01/2018
1	Protein CIBA 01/2018
1	Endothelial Protein C ReceptorIBA 01/2018
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2017
1	NucleotidesIBA 06/2017
1	Transforming Growth Factor-beta Type II ReceptorIBA 06/2017
1	Tranexamic Acid (AMCA)FDA Link 03/2017
1	ORALIT (ORS)IBA 05/2014
1	danaparoid (Orgaran)FDA Link 01/2012
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2011
1	Complement System Proteins (Complement)IBA 01/2011
1	Atrial Natriuretic Factor (ANF)IBA 09/2010
1	ElectrolytesIBA 01/2010

Therapy/Procedure

25	Therapeutics 05/2022 - 10/2008
10	Endarterectomy (Thromboendarterectomy) 11/2019 - 10/2008
5	Secondary Prevention 01/2022 - 11/2016
5	Aftercare (After-Treatment) 11/2019 - 01/2017
3	Length of Stay 01/2022 - 01/2003
2	Polypharmacy 01/2022 - 01/2018
2	Thrombectomy 09/2021 - 01/2018
2	Stents 11/2019 - 10/2008
2	Time-to-Treatment 12/2009 - 08/2009
1	Punctures 06/2022
1	Patient Admission (Patient Admissions) 06/2022
1	General Anesthesia 01/2022
1	Neurological Rehabilitation 08/2021
1	Contraindications 11/2019
1	Diagnostic Equipment 09/2018
1	Treatment Delay 10/2013
1	Carotid Endarterectomy 01/2012
1	Conservative Treatment 01/2011